Credit Suisse’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.99M | Buy |
51,278
+1,410
| +3% | +$54.7K | ﹤0.01% | 1858 |
|
2023
Q4 | $1.53M | Buy |
49,868
+1,788
| +4% | +$55K | ﹤0.01% | 2054 |
|
2023
Q3 | $1.07M | Buy |
48,080
+7,252
| +18% | +$162K | ﹤0.01% | 2244 |
|
2023
Q2 | $877K | Buy |
40,828
+1,309
| +3% | +$28.1K | ﹤0.01% | 2456 |
|
2023
Q1 | $948K | Buy |
39,519
+3,028
| +8% | +$72.6K | ﹤0.01% | 2347 |
|
2022
Q4 | $847K | Buy |
36,491
+10,997
| +43% | +$255K | ﹤0.01% | 2442 |
|
2022
Q3 | $408K | Buy |
25,494
+197
| +0.8% | +$3.15K | ﹤0.01% | 2892 |
|
2022
Q2 | $448K | Buy |
25,297
+12
| +0% | +$213 | ﹤0.01% | 2896 |
|
2022
Q1 | $515K | Buy |
25,285
+1,671
| +7% | +$34K | ﹤0.01% | 2938 |
|
2021
Q4 | $441K | Buy |
23,614
+1,584
| +7% | +$29.6K | ﹤0.01% | 3109 |
|
2021
Q3 | $435K | Sell |
22,030
-5,199
| -19% | -$103K | ﹤0.01% | 3075 |
|
2021
Q2 | $644K | Buy |
27,229
+172
| +0.6% | +$4.07K | ﹤0.01% | 2877 |
|
2021
Q1 | $641K | Sell |
27,057
-10,387
| -28% | -$246K | ﹤0.01% | 2813 |
|
2020
Q4 | $751K | Buy |
37,444
+12,757
| +52% | +$256K | ﹤0.01% | 2755 |
|
2020
Q3 | $513K | Buy |
24,687
+2,108
| +9% | +$43.8K | ﹤0.01% | 2670 |
|
2020
Q2 | $395K | Sell |
22,579
-5,481
| -20% | -$95.9K | ﹤0.01% | 2823 |
|
2020
Q1 | $458K | Sell |
28,060
-13,841
| -33% | -$226K | ﹤0.01% | 2580 |
|
2019
Q4 | $863K | Buy |
41,901
+14,847
| +55% | +$306K | ﹤0.01% | 2614 |
|
2019
Q3 | $311K | Sell |
27,054
-28,242
| -51% | -$325K | ﹤0.01% | 3019 |
|
2019
Q2 | $727K | Buy |
55,296
+27,731
| +101% | +$365K | ﹤0.01% | 2563 |
|
2019
Q1 | $418K | Buy |
27,565
+1,632
| +6% | +$24.7K | ﹤0.01% | 2866 |
|
2018
Q4 | $445K | Buy |
25,933
+5,029
| +24% | +$86.3K | ﹤0.01% | 2799 |
|
2018
Q3 | $308K | Sell |
20,904
-8,560
| -29% | -$126K | ﹤0.01% | 3041 |
|
2018
Q2 | $703K | Sell |
29,464
-46,620
| -61% | -$1.11M | ﹤0.01% | 2806 |
|
2018
Q1 | $1.94M | Buy |
76,084
+47,000
| +162% | +$1.2M | ﹤0.01% | 2085 |
|
2017
Q4 | $536K | Buy |
29,084
+10,652
| +58% | +$196K | ﹤0.01% | 2915 |
|
2017
Q3 | $193K | Buy |
+18,432
| New | +$193K | ﹤0.01% | 3452 |
|
2017
Q2 | – | Sell |
-13,630
| Closed | -$137K | – | 3431 |
|
2017
Q1 | $137K | Buy |
13,630
+1,173
| +9% | +$11.8K | ﹤0.01% | 3300 |
|
2016
Q4 | $194K | Buy |
12,457
+610
| +5% | +$9.5K | ﹤0.01% | 3462 |
|
2016
Q3 | $228K | Sell |
11,847
-15,643
| -57% | -$301K | ﹤0.01% | 3426 |
|
2016
Q2 | $326K | Buy |
+27,490
| New | +$326K | ﹤0.01% | 3355 |
|